That changed in 2025 with the publication of SURMOUNT-5, the first randomized head-to-head trial, published in the New England Journal of Medicine
The ads that stick are the ones that speak to how people feel
Generally, you should continue established IBS therapies including antispasmodics, fiber supplements, and probiotics unless side effects become problematic
Originally designed to help manage type 2 diabetes, GLP-1 receptor agonists have gained widespread attention for another reason: their ability to support significant, sustained weight loss
Combining adequate protein intake (1.2 to 1.6 g/kg daily), consistent resistance training, and targeted therapies like peptide therapy can protect your muscle while maximizing fat loss
doi: 10.1016/j.tem.2020.02.006 24 MinTBainSC